More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
In a recent study published in the journal Nature Medicine, researchers examine clinical glioblastoma and benign intracranial samples to determine the presence and function of immune cells in the ...
The clearance was granted based on demonstrated substantial equivalence to SmartPReP, a globally recognized standard system ...
Cellular therapies that harness a patient’s own immune system to identify and eliminate cancer cells are rapidly expanding ...
Pilot studies have shown encouraging results that are supporting the company’s pre-IND enabling development, marking a critical step toward clinical translation of the Bone Marrow Organoid technology ...
Families across Central Texas can now access lifesaving pediatric bone marrow transplants, which has eliminated the need to travel for advanced cancer care, Dell Children's physicians said.
A new study provides a powerful way to study infections in environments that closely mimic human organs. The strategy, tested in a bone-marrow-on-chip model, was developed by researchers from the ...
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results